The 2nd International Annual Congress on Controversies on Cannabis-Based Medicines (Med-Cannabis2019), 23-24 May 2019, Barcelona, Spain.


Program Highlights

Translational Research Program Surrounding Cannabis and Cannabinoids
Carolyn Baglole, McGill University, Canada 

The Endocannabinoid System as a Novel Therapeutic Target for Pain and CNS Disorders: Can the Promise be Realised?
David Finn, National University of Ireland, Ireland

Psychosocial Consequences of Regular Recreational Cannabis Use
Eva Hoch, Ludwig Maximilian University, Germany 

Position of the European Pain Federation EFIC® on Appropriate Use of Cannabis‐Based Medicines and Medical Cannabis for Chronic Pain Management
Bart Morlion, European Pain Federation EFIC, Belgium

State of Medical Cannabis Education in the EU and the World
Gregor Zorn, European Cannabinoid Therapy Association – ECTA, Slovenia

Long-Term Treatment with Cannabis in Fibromyalgia
Piercarlo Sarzi-Puttini, ASST Fatebenefratelli-Sacco, University of Milan, Italy

Systematic Review and Meta-Analysis of Cannabis-Based Medicines for Cancer Pain
Winfried Häuser, Klinikum Saarbrücken, Germany